Paraoxonase 1 activity in human beings is very low at birth and increases with time.47 As our meta‐analysis has demonstrated the significant role of paraoxonase 1 activity in DM and diabetic complications, therapeutic strategies targeting this enzyme maybe reasonable. This evidence concerns the gene PON1 and diabetes mellitus.